Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Awad, Raef ^a,b   Fogarty, Gerald ^a,b   Hong, Angela ^c,d   Kelly, Patricia ^a,b   Ng, Diana ^a,b   Santos, Daniel ^a,b   Haydu, Lauren ^c,e  

^a Genesis Cancer Care   (Australia)

^b Mater Hospital   (Australia)

^c MELANOMA INSTITUTE AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Brain metastases; Hippocampal avoidance; Melanoma; SIB; VMAT

Indexed keywords

IPILIMUMAB;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN NECROSIS; BRAIN SIZE; BRAIN STEM; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EYE; FEMALE; FOLLOW UP; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC NERVE; OVERALL SURVIVAL; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; SARCOMA; TREATMENT INDICATION; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC THERAPY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HIPPOCAMPUS; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; ORGANS AT RISK; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SARCOMA; SKIN DISEASES; TREATMENT OUTCOME;

EID: 84875027404     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-62     Document Type: Article

References (33)

1. Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981, 8(1):26-30. 10.1227/00006123-198101000-00006, 7207769.
2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42(2):660-668. 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E, 679158.
3. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135(6):807-810. 10.1016/0002-9610(78)90171-X, 665907.
4. Arbit E, Wronski M. Clinical decision making in brain metastases. Neurosurg Clin N Am 1996, 7(3):447-457.
5. Davey P, O'Brien PF, Schwartz ML, Cooper PW. A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases. Br J Neurosurg 1994, 8(6):717-723. 10.3109/02688699409101186, 7718169.
6. Carella RJ, Gelber R, Hendrickson F, Berry HC, Cooper JS. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II. Cancer 1980, 45(4):679-683. 10.1002/1097-0142(19800215)45:4<679::AID-CNCR2820450410>3.0.CO;2-J, 6766793.
7. Gottlieb GL, Agarwal GC. The role of the myotatic reflex in the voluntary control of movements. Brain Res 1972, 40(1):139-143. 10.1016/0006-8993(72)90119-9, 5033792.
8. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63(1):37-46. 10.1016/j.ijrobp.2005.05.023, 16111570.
9. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10(11):1037-1044. 10.1016/S1470-2045(09)70263-3, 19801201.
10. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003, 29(6):533-540. 10.1016/S0305-7372(03)00105-1, 14585263.
11. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Jama 1998, 280(17):1485-1489. 10.1001/jama.280.17.1485, 9809728.
12. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39(6):789-796. 10.1212/WNL.39.6.789, 2725874.
13. Ghia A, Tome WA, Thomas S, Cannon G, Khuntia D, Kuo JS, Mehta MP. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys 2007, 68(4):971-977. 10.1016/j.ijrobp.2007.02.016, 17446005.
14. Gutierrez AN, Westerly DC, Tome WA, Jaradat HA, Mackie TR, Bentzen SM, Khuntia D, Mehta MP. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007, 69(2):589-597. 10.1016/j.ijrobp.2007.05.038, 2350212, 17869672.
15. Fogarty GB, Ng D, Liu G, Haydu LE, Bhandari N. Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy-a comparison among prostate cancer patients treated in an Australian centre. Radiat Oncol 2011 Sep 5, 6:108.
16. Bauman G, Yartsev S, Fisher B, Kron T, Laperriere N, Heydarian M, VanDyk J. Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases. Am J Clin Oncol 2007, 30(1):38-44. 10.1097/01.coc.0000245473.41035.c4, 17278893.
17. Lagerwaard FJ, van der Hoorn EA, Verbakel WF, Haasbeek CJ, Slotman BJ, Senan S. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2009, 75(1):253-259. 10.1016/j.ijrobp.2009.03.029, 19577856.
18. International commission on radiation units and measurements Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50) 1999, Bethesda: ICRU, International commission on radiation units and measurements.
19. Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoli R, Martin L. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 1993, 27(5):1231-1239. 10.1016/0360-3016(93)90548-A, 8262852.
20. Depuydt T, Van Esch A, Huyskens DP. A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation. Radiother Oncol 2002, 62(3):309-319. 10.1016/S0167-8140(01)00497-2, 12175562.
21. Du Four S, Wilgenhof S, Duerinck J, Michotte A, Binst AV, Ridder MD, Neyns B. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies. Eur J Cancer 2012 Nov, 48(16):3045-3051.
22. Hsu F, Carolan H, Nichol A, Cao F, Nuraney N, Lee R, Gete E, Wong F, Schmuland M, Heran M. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2010 Apr, 76(5):1480-1485.
23. Nakamura JL, Verhey LJ, Smith V, Petti PL, Lamborn KR, Larson DA, Wara WM, McDermott MW, Sneed PK. Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys 2001, 51(5):1313-1319. 10.1016/S0360-3016(01)01757-6, 11728692.
24. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 1998, 42(3):581-589. 10.1016/S0360-3016(98)00272-7, 9806518.
25. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL. Stereotactic radiosurgery for patients with " radioresistant" brain metastases. Neurosurgery 2002, 51(3):656-665. discussion 665-657.
26. Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, Petti PL, Smith V, Verhey LJ, Wara WM. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998, 4(2):103-109.
27. Rades D, Heisterkamp C, Huttenlocher S, Bohlen G, Dunst J, Haatanen T, Schild SE. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Int J Radiat Oncol Biol Phys 2010 Jun 1, 77(2):537-541.
28. Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine WF. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 2004, 59(1):87-93. 10.1016/j.ijrobp.2003.10.009, 15093903.
29. Gaudy-Marqueste C, Regis JM, Muracciole X, Laurans R, Richard MA, Bonerandi JJ, Grob JJ. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65(3):809-816. 10.1016/j.ijrobp.2006.01.024, 16682138.
30. Weber DC, Caparrotti F, Laouiti M, Malek K. Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life. Radiat Oncol 2011 Jun 30, 6:79.
31. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012 Feb 1, 30(4):419-425.
32. Rodrigues G, Eppinga W, Lagerwaard F, de Haan P, Haasbeek C, Perera F, Slotman B, Yaremko B, Yartsev S, Bauman G. A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases. Radiother Oncol 2012 Feb, 102(2):180-186.
33. Bhatia S, Thompson JA. Systemic therapy for metastatic melanoma in 2012: dawn of a new era. J Natl Compr Canc Netw 2012 Mar, 10(3):403-412.